Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 4.574
Filtrar
1.
Natl Med J India ; 37(4): 203-204, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39448533

RESUMO

Scrub typhus presenting as infective endocarditis of the mitral valve is rare. There are few reports of infective endocarditis by scrub typhus with just one previous report of involvement of the aortic valve. An 18-year-old woman presented with prolonged fever for 1 month. Her repeated blood cultures were negative. She was finally diagnosed to have scrub typhus with scrub typhus IgM being positive and became afebrile with prolonged oral doxycycline monotherapy. Although atypical organisms such as Legionella, Mycoplasma and Coxiella are described to cause culture-negative endocarditis, vegetations were present on both the anterior and posterior mitral valve leaflets in our patient.


Assuntos
Endocardite Bacteriana , Valva Mitral , Tifo por Ácaros , Humanos , Feminino , Tifo por Ácaros/diagnóstico , Tifo por Ácaros/tratamento farmacológico , Tifo por Ácaros/complicações , Adolescente , Valva Mitral/microbiologia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/tratamento farmacológico , Doxiciclina/uso terapêutico , Doxiciclina/administração & dosagem , Antibacterianos/uso terapêutico , Antibacterianos/administração & dosagem
2.
BMJ Case Rep ; 17(10)2024 Oct 30.
Artigo em Inglês | MEDLINE | ID: mdl-39477448

RESUMO

Our case highlights an atypical presentation of Coxiella burnetii endocarditis with acute ischaemic stroke in a male patient in his 60s. The patient had undergone a congenital bicuspid aortic valve replacement with a bioprosthetic valve and an ascending aortic root graft with a pacemaker. He experienced intermittent fevers, chills and malaise over 15 months leading up to his presentation. During our diagnostic process, we used the newly developed Karius test, which detects microbial cell-free DNA in the patient's serum. The patient was treated with doxycycline and hydroxychloroquine for 24 months along with surgical removal and replacement of his aortic valve and graft. Our case underscores the utility of the Karius test and the essential role of neurology in the multidisciplinary team.


Assuntos
Coxiella burnetii , Endocardite Bacteriana , AVC Isquêmico , Febre Q , Humanos , Masculino , Febre Q/diagnóstico , Febre Q/complicações , AVC Isquêmico/diagnóstico , AVC Isquêmico/microbiologia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/complicações , Endocardite Bacteriana/tratamento farmacológico , Coxiella burnetii/isolamento & purificação , Pessoa de Meia-Idade , Antibacterianos/uso terapêutico , Doxiciclina/uso terapêutico , Valva Aórtica/microbiologia , Valva Aórtica/cirurgia , Valva Aórtica/diagnóstico por imagem , Hidroxicloroquina/uso terapêutico
3.
Dtsch Med Wochenschr ; 149(22): 1356-1360, 2024 Nov.
Artigo em Alemão | MEDLINE | ID: mdl-39437828

RESUMO

A succinct summary of the 2023 guidelines on the management of infectious endocarditis of the European Society of Cardiology is presented. Main new aspects are (1) the importance of treating complicated endocarditis at a hospital with an endocarditis team and cardiac surgery, (2) a less restrictive recommendation for antibiotic prophylaxis, which now favors an individualized indication in patients with intermediary risk, e.g. bicuspid aortic valve and degenerative or rheumatic native valve disease, undergoing orodental interventions, while there is a clear recommendation for prophylaxis in high-risk patients (e.g. having prosthetic valves). (3) In patients with left-sided endocarditis caused by streptococci, enterococcus faecalis, staphylococcus aureus, or coagulase-negative staphylococci, who are stable after at least 10 days of in-hospital intravenous appropriate antibiotic therapy, step-down ambulatory (oral or parenteral) further antibiotic therapy is recommended.


Assuntos
Antibacterianos , Humanos , Antibacterianos/uso terapêutico , Guias de Prática Clínica como Assunto , Endocardite/terapia , Endocardite/diagnóstico , Antibioticoprofilaxia , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/terapia , Europa (Continente) , Cardiologia/normas
4.
BMC Infect Dis ; 24(1): 939, 2024 Sep 09.
Artigo em Inglês | MEDLINE | ID: mdl-39251918

RESUMO

BACKGROUND: Corynebacterium striatum (C. striatum) is a gram-positive, anaerobic bacillus found both environmentally and in human skin and nasal mucosa flora. It is reportedly the etiologic agent of community-acquired and nosocomial diseases and is significantly associated with bacteremia and medical endovascular devices. This is the rare case of mitral valve native valve endocarditis (NVE) caused by C. striatum occurring in a young adult without underlying structural heart disease or indwelling cardiovascular medical devices successfully treated with multidisciplinary therapy. CASE PRESENTATION: The patient was a 28-year-old female with no medical history. She was transferred our hospital due to sudden onset of vertigo and vomit. A computed tomography on day 2 revealed the hydrocephalus due to the cerebellar infarction, and she underwent posterior fossa decompression for cerebellar infarction. An angiography on day 8 revealed a left vertebral artery dissection, which was suspected be the etiology. Afterwards, a sudden fever of 39 degrees developed on day 38. She was diagnosed with aspiration pneumonia and treated with ampicillin/sulbactam but was still febrile at the time of transfer for rehabilitation. Treatment continued with levofloxacin, the patient had no fever decline, and she was readmitted to our hospital. Readmission blood cultures (3/3 sets) revealed C. striatum, and an echocardiogram revealed an 11 mm long mitral valve vegetation, leading to NVE diagnosis. On the sixth illness day, cardiac failure symptoms manifested. Echocardiography revealed mitral valve rupture. She was transferred again on the 11th day of illness, during which time her mitral valve was replaced. C. striatum was detected in the vegetation. Following surgery, she returned to our hospital, and vancomycin administration continued. The patient was discharged after 31 total days of postoperative antimicrobial therapy. The patient experienced no exacerbations thereafter. CONCLUSIONS: We report the rare case of C. striatum mitral valve NVE in a young adult without structural heart disease or indwelling cardiovascular devices. CLINICAL TRIAL NUMBER: Not applicable.


Assuntos
Antibacterianos , Infecções por Corynebacterium , Corynebacterium , Endocardite Bacteriana , Humanos , Feminino , Adulto , Infecções por Corynebacterium/microbiologia , Infecções por Corynebacterium/tratamento farmacológico , Corynebacterium/isolamento & purificação , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/tratamento farmacológico , Antibacterianos/uso terapêutico , Valva Mitral/cirurgia , Valva Mitral/microbiologia
5.
J Med Case Rep ; 18(1): 448, 2024 Sep 26.
Artigo em Inglês | MEDLINE | ID: mdl-39322947

RESUMO

BACKGROUND: Infective endocarditis is an uncommon but well-known post-transplant complication with significant morbidity and mortality. It has been observed to be about 171 times more common in solid organ transplant patients than in the general population. With the increasing rate of end-stage kidney disease, the higher demand for kidney transplantation with better graft survival, and life expectancy rates, more transplant recipients may develop infective endocarditis as a late post-transplant complication. Prompt diagnosis of infective endocarditis is therefore necessary to avert graft loss and other life-threatening outcomes. CASE PRESENTATION: We present a case of a 52-year-old African patient who had a live donor kidney transplant 18 months prior to presentation and had been on oral tacrolimus 5 mg every morning/4.5 mg every evening, mycophenolic acid (MPA) 720 mg twice daily, and oral prednisolone 10 mg daily as maintenance immunosuppressive medications. Regarding the above immunosuppressive medications, he had been in good health and had a functioning transplant graft. He presented with a resolving right thigh swelling, recurrence of fever, new onset left hemiplegia, and seizures. Enterococcus faecalis infective endocarditis was diagnosed with metastatic brain abscesses, which was treated with intravenous vancomycin and gentamycin for 5 weeks. There are very few reported cases of infective endocarditis due to Enterococcus faecalis, and this case is unique because the initial presentation was pyomyositis. CONCLUSION: Infective endocarditis with septic embolization to the brain should be considered in kidney transplant recipients with pyomyositis and multiple rim-enhancing lesions, especially in the late post-transplant period with Enterococcal spp. as an emerging cause of infective endocarditis in kidney transplant recipients. Clinicians will need to have a high index of suspicion to aid early diagnosis with appropriate treatment to prevent adverse outcomes.


Assuntos
Transplante de Rim , Humanos , Transplante de Rim/efeitos adversos , Pessoa de Meia-Idade , Masculino , Enterococcus faecalis , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Endocardite Bacteriana/tratamento farmacológico , Antibacterianos/uso terapêutico , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Infecções por Bactérias Gram-Positivas/diagnóstico
6.
Diagn Microbiol Infect Dis ; 110(4): 116535, 2024 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-39260018

RESUMO

The diagnosis of Bartonella is challenging due to its rarity and negative culture results. Once the diagnosis is delayed and proper treatment is not given, it can develop into infective endocarditis, which can be fatal. We reported a 60-year-old female patient who had recurrent fever for 5 months. After receiving ineffective treatment at the local hospital, she sought medical attention at our hospital. Laboratory blood indicators testing and imaging indicated infective endocarditis, and metagenomic Next Generation Sequencing (m-NGS) testing confirmed the diagnosis of Bartonella vinsonii infection. After surgical treatment and the combination of doxycycline and ceftriaxone sodium for anti-infective therapy, the patient recovered. Valuing the combination of multiple auxiliary diagnostic methods and improving the application of m-NGS in the detection of unknown pathogens can compensate for the current limitations in the diagnosis of Bartonella. Early diagnosis and treatment are extremely important for Bartonella endocarditis.


Assuntos
Antibacterianos , Infecções por Bartonella , Bartonella , Endocardite Bacteriana , Humanos , Feminino , Pessoa de Meia-Idade , Bartonella/genética , Bartonella/isolamento & purificação , Infecções por Bartonella/diagnóstico , Infecções por Bartonella/microbiologia , Infecções por Bartonella/tratamento farmacológico , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/tratamento farmacológico , Antibacterianos/uso terapêutico , Doxiciclina/uso terapêutico , Sequenciamento de Nucleotídeos em Larga Escala , Ceftriaxona/uso terapêutico , Resultado do Tratamento , Metagenômica
8.
BMC Nephrol ; 25(1): 291, 2024 Sep 04.
Artigo em Inglês | MEDLINE | ID: mdl-39232673

RESUMO

BACKGROUND: Membranoproliferative glomerulonephritis is a rare entity which can be a result from autoimmune diseases, caused by various medications and infections. CASE PRESENTATION: We herein present the case of a 62-year-old male patient who presented with fatigue and was found to have severe anemia, impaired renal function, and nephrotic syndrome. A renal biopsy revealed membranoproliferative glomerulonephritis (MPGN) of the immune complex type with activation of the classical complement pathway. Further investigations led to the diagnosis of a chronic Coxiella burnetii-infection (Q fever), likely acquired during cycling trips in a region known for intensive sheep farming. Additionally, the patient was found to have a post endocarditic destructive bicuspid aortic valve caused by this pathogen. Treatment with hydroxychloroquine and doxycycline was administered for a duration of 24 months. The aortic valve was replaced successfully and the patient recovered completely. CONCLUSIONS: Early detection and targeted treatment of this life-threatening disease is crucial for complete recovery of the patient.


Assuntos
Endocardite Bacteriana , Glomerulonefrite Membranoproliferativa , Febre Q , Humanos , Masculino , Febre Q/complicações , Febre Q/tratamento farmacológico , Febre Q/diagnóstico , Glomerulonefrite Membranoproliferativa/etiologia , Glomerulonefrite Membranoproliferativa/complicações , Glomerulonefrite Membranoproliferativa/tratamento farmacológico , Pessoa de Meia-Idade , Endocardite Bacteriana/complicações , Endocardite Bacteriana/tratamento farmacológico , Hidroxicloroquina/uso terapêutico , Doença Crônica , Doxiciclina/uso terapêutico , Valva Aórtica/patologia , Valva Aórtica/diagnóstico por imagem , Antibacterianos/uso terapêutico , Doença da Válvula Aórtica Bicúspide/complicações
9.
BMC Infect Dis ; 24(1): 771, 2024 Aug 02.
Artigo em Inglês | MEDLINE | ID: mdl-39095695

RESUMO

BACKGROUND: Klebsiella pneumoniae invasive syndrome (KPIS) is characterized by primary pyogenic liver abscess associated with metastatic infections. Although rare, Klebsiella endocarditis carries a high mortality risk. CASE PRESENTATION: A 60-year-old lady with type II diabetes mellitus presented with fever, malaise, right hypochondriac pain and vomiting for two weeks. Ultrasound abdomen revealed a collection within liver, and distended gallbladder with echogenic debris within. 3 days after ultrasound guided pigtail drainage of gallbladder empyema, newly presence murmur detected. Pus, urine, and blood cultures obtained were positive for Klebsiella pneumonia. Echocardiogram exhibited oscillating mass attached to anterior mitral valve leaflet. After 6 weeks of intravenous ceftriaxone, follow-up echocardiogram and ultrasound showed complete resolution of mitral valve vegetation, hepatic and gallbladder collection. CONCLUSION: Concomitant extrahepatic infective endocarditis (IE) should raise concerns in daily practice for patients with Klebsiella pneumoniae liver abscesses, despite the rarity of Klebsiella endocarditis. In the absence of diagnostic suspicion, antibiotic treatment regimens may be shortened, and adverse effects from IE infection may ensue.


Assuntos
Antibacterianos , Infecções por Klebsiella , Klebsiella pneumoniae , Abscesso Hepático , Humanos , Klebsiella pneumoniae/isolamento & purificação , Pessoa de Meia-Idade , Feminino , Infecções por Klebsiella/tratamento farmacológico , Infecções por Klebsiella/microbiologia , Infecções por Klebsiella/complicações , Infecções por Klebsiella/diagnóstico , Antibacterianos/uso terapêutico , Abscesso Hepático/microbiologia , Abscesso Hepático/complicações , Abscesso Hepático/tratamento farmacológico , Abscesso Hepático/diagnóstico por imagem , Empiema/microbiologia , Empiema/tratamento farmacológico , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/complicações , Endocardite Bacteriana/diagnóstico , Doenças da Vesícula Biliar/microbiologia , Doenças da Vesícula Biliar/complicações
10.
BMC Infect Dis ; 24(1): 766, 2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-39090536

RESUMO

BACKGROUND: Coxiella burnetii is a bacterium with extreme tenacity and contagiousness that is mainly transmitted by inhalation of contaminated aerosols. Nevertheless, a transmission by ticks is under discussion. We report a case of Q fever in an urban environment and far away from sheep breeding that caused a rare right-sided endocarditis. CASE PRESENTATION: A 55-year-old man who was in good health before the event developed a C. burnetii -endocarditis of the tricuspid valve. He had no contact with sheep and no recent travel in a rural or even endemic area. The infection originated in a strictly urban environment, and the patient's occupation as a cemetery gardener in Berlin, coupled with the close temporal and local exposure to wild boar, made a transmission by these animals a plausible hypothesis. The infection was confirmed by the German Reference Laboratory, and the patient recovered completely after treatment with doxycycline and hydrochlorquine. CONCLUSIONS: The specialities of this case report are the right-sided endocarditis and the transmission of C. burnetii in a metropolitan area without sheep contact. We think that this case should serve to increase awareness of the potential for Q fever infection even in non-rural areas.


Assuntos
Coxiella burnetii , Endocardite Bacteriana , Febre Q , Valva Tricúspide , Febre Q/transmissão , Febre Q/microbiologia , Febre Q/diagnóstico , Febre Q/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Humanos , Valva Tricúspide/microbiologia , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/transmissão , Endocardite Bacteriana/tratamento farmacológico , Coxiella burnetii/isolamento & purificação , Animais , Antibacterianos/uso terapêutico , Doxiciclina/uso terapêutico , Ovinos
11.
J Investig Med High Impact Case Rep ; 12: 23247096241265917, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39107989

RESUMO

Multivalvular endocarditis is a rare and potentially fatal complication that can occur in people who inject drugs. Currently, there are few cases that have been studied or reported in literature. A complication of this manifestation that worsens prognosis and treatment is the distribution of septic emboli throughout the body which highlights the dissemination of the infection. There are no specific guidelines on the treatment of multivalvular endocarditis, but its complexity can present challenges in administering medical and surgical treatment. In this case of a 37-year-old man with infective endocarditis of 3 valves, a comprehensive work-up found septic emboli in the lungs, kidneys, ribs, spine, and brain with ophthalmologic involvement that resulted in visual impairment. This case highlights important complications that can occur with septic emboli and management of these issues using a multidisciplinary approach including the treatment of substance use disorder.


Assuntos
Endocardite Bacteriana , Infecções Estafilocócicas , Staphylococcus aureus , Humanos , Masculino , Adulto , Infecções Estafilocócicas/tratamento farmacológico , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/complicações , Staphylococcus aureus/isolamento & purificação , Antibacterianos/uso terapêutico , Abuso de Substâncias por Via Intravenosa/complicações , Embolia/etiologia
12.
APMIS ; 132(10): 675-687, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-39007242

RESUMO

Infective endocarditis (IE) is a severe infection of the inner heart. Even with current standard treatment, the mean in-hospital mortality is as high as 15-20%, and 1-year mortality is up to 40% for left-sided IE. Importantly, IE mortality rates have not changed substantially over the past 30 years, and the incidence of IE is rising. The treatment is challenging due to the bacterial biofilm mode of growth inside the heart valve vegetations, resulting in antibiotic tolerance. Achieving sufficient antibiotic anti-biofilm concentrations in the biofilms of the heart valve vegetations is problematic, even with high-dose and long-term antibiotic therapy. The increasing prevalence of IE caused by antibiotic-resistant bacteria adds to the challenge. Therefore, adjunctive antibiotic-potentiating drug candidates and strategies are increasingly being investigated. Bacteriophage therapy is a reemerging antibacterial treatment strategy for difficult-to-treat infections, mainly biofilm-associated and caused by multidrug-resistant bacteria. However, significant knowledge gaps regarding the safety and efficacy of phage therapy impede more widespread implementation in clinical practice. Hopefully, future preclinical and clinical testing will reveal whether it is a viable treatment. The objective of the present review is to assess whether bacteriophage therapy is a realistic treatment for IE.


Assuntos
Biofilmes , Terapia por Fagos , Humanos , Terapia por Fagos/métodos , Biofilmes/crescimento & desenvolvimento , Antibacterianos/uso terapêutico , Endocardite/terapia , Endocardite/microbiologia , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/terapia , Endocardite Bacteriana/tratamento farmacológico , Bacteriófagos/fisiologia , Farmacorresistência Bacteriana Múltipla
13.
Intern Med ; 63(15): 2209-2214, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39085093

RESUMO

A 66-year-old woman with liver cirrhosis and hemodialysis was referred with a 1-week history of pain and rash on the left lower leg. On an examination, the patient was in shock. She was administered catecholamine support for septic shock and ampicillin/sulbactam for severe cellulitis. Streptococcus dysgalactiae subsp. equisimilis (SDSE) was isolated from the blood culture, and she was diagnosed with streptococcal toxic shock syndrome. Despite therapy, the patient died on day 7 of admission. Infective endocarditis (IE) was diagnosed during an autopsy. Clinicians should be aware that overwhelming SDSE-IE can occur even in the absence of necrotizing fasciitis, especially in immunocompromised patients.


Assuntos
Autopsia , Endocardite Bacteriana , Choque Séptico , Infecções Estreptocócicas , Streptococcus , Humanos , Choque Séptico/microbiologia , Choque Séptico/diagnóstico , Feminino , Idoso , Infecções Estreptocócicas/diagnóstico , Infecções Estreptocócicas/complicações , Infecções Estreptocócicas/microbiologia , Streptococcus/isolamento & purificação , Evolução Fatal , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/complicações , Endocardite Bacteriana/tratamento farmacológico
14.
S D Med ; 77(6): 262-265, 2024 06.
Artigo em Inglês | MEDLINE | ID: mdl-39013098

RESUMO

Nocardia paucivorans is a rarely cultured bacteria most commonly found in immunocompromised hosts, and rarely, may result in dissemination across multiple organ systems. Infection and subsequent clinical manifestations are often vague and nonspecific, making timely diagnosis difficult. Due to the infrequency of N. paucivorans infection, no consensus treatment has yet been established. We report a case of an immunocompromised patient with disseminated nocardiosis with infective endocarditis and other extrapulmonary involvement.


Assuntos
Hospedeiro Imunocomprometido , Nocardiose , Nocardia , Humanos , Nocardiose/diagnóstico , Nocardiose/tratamento farmacológico , Nocardiose/microbiologia , Nocardia/isolamento & purificação , Masculino , Antibacterianos/uso terapêutico , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/tratamento farmacológico , Pessoa de Meia-Idade
15.
BMC Infect Dis ; 24(1): 698, 2024 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-39004701

RESUMO

INTRODUCTION: Infective endocarditis is a rare but potentially severe disease, associated with significant morbidity and mortality. Our study aims to describe the epidemiology and management aspects of endocarditis in northern Morocco and compare it with international management guidelines. MATERIALS AND METHODS: This is a retrospective study involving all patients hospitalized in the cardiology department of the University Hospital of Tangier for infective endocarditis over a period of 4 years and 7 months, from May 2019 to February 2024. RESULTS: Eighty patients were hospitalized for IE during the study period. The average age of the patients was 46 years, with an even sex ratio. IE concerned native valves in 77% of cases, mechanical prostheses in 19% of cases, and on bio prostheses in 4%. The average diagnostic delay was 25 days. Blood cultures were negative in 59% of cases. The predominant infective microorganism was the bacteria Staphylococcus (65.6%). Imaging results showed vegetations in 76.3% of cases, predominantly on the mitral valve (39.3%), followed by the aortic valve (21.3%). The main complications included heart failure (51.2%), peripheral arterial embolisms (22.5%) and splenic infarction (17.5%). Management wise, the most commonly used antibiotic therapy was a combination of ceftriaxone and gentamicin. Clinical and biological improvement was observed in 70% of cases, with a mortality rate of 12.5%. Twelve patients underwent surgery (15%). Urgent surgery was indicated in 66,7% of the operated patients. CONCLUSION: Our study highlights the challenges in managing infective endocarditis in northern Morocco. The prognosis of infective endocarditis can be improved through multidisciplinary management within the implementation of an Endocarditis Team.


Assuntos
Antibacterianos , Endocardite , Humanos , Marrocos/epidemiologia , Masculino , Feminino , Pessoa de Meia-Idade , Estudos Retrospectivos , Adulto , Prognóstico , Endocardite/epidemiologia , Endocardite/microbiologia , Endocardite/diagnóstico , Endocardite/terapia , Endocardite/mortalidade , Antibacterianos/uso terapêutico , Idoso , Endocardite Bacteriana/epidemiologia , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/mortalidade , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/tratamento farmacológico , Adulto Jovem , Adolescente
16.
BMJ Case Rep ; 17(7)2024 Jul 29.
Artigo em Inglês | MEDLINE | ID: mdl-39074945

RESUMO

SummaryWe describe a case of culture-negative infective endocarditis due to Neisseria gonorrhoeae, where the application of metagenomics shotgun sequencing in blood played a pivotal role in elucidating the underlying aetiology, guiding targeted therapy and ultimately resulting in the patient's complete recovery. Beyond its immediate clinical impact, prompt treatment bears significant implications for public health. The utilisation of molecular testing emerges as a valuable strategy to enhance diagnostic accuracy, particularly in cases involving fastidious organisms that are infrequently associated with infective endocarditis.


Assuntos
Antibacterianos , Endocardite Bacteriana , Gonorreia , Neisseria gonorrhoeae , Valva Tricúspide , Humanos , Gonorreia/diagnóstico , Gonorreia/tratamento farmacológico , Gonorreia/complicações , Neisseria gonorrhoeae/isolamento & purificação , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/tratamento farmacológico , Masculino , Valva Tricúspide/microbiologia , Antibacterianos/uso terapêutico , Ceftriaxona/uso terapêutico , Adulto , Ecocardiografia
17.
Diagn Microbiol Infect Dis ; 110(1): 116285, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39018935

RESUMO

Parvimonas micra, a gram-positive anaerobic bacterium, has garnered increased attention due to its role in infective endocarditis. We present a challenging prosthetic valve endocarditis caused by Parvimonas micra in a patient with a complex cardiac history involving multiple surgeries. The case highlights the difficulties in diagnosis and treatment, emphasizing the importance of advanced diagnostic techniques, including metagenomics next-generation sequencing (mNGS). Additionally, it underscores the need for heightened vigilance regarding oral symptoms and the potential risk of bacteremia in post-valvular surgery patients. This report contributes to a better understanding of Parvimonas micra-associated endocarditis and its unique characteristics.


Assuntos
Endocardite Bacteriana , Firmicutes , Infecções por Bactérias Gram-Positivas , Próteses Valvulares Cardíacas , Infecções Relacionadas à Prótese , Humanos , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/tratamento farmacológico , Infecções Relacionadas à Prótese/microbiologia , Infecções Relacionadas à Prótese/diagnóstico , Infecções Relacionadas à Prótese/tratamento farmacológico , Próteses Valvulares Cardíacas/efeitos adversos , Próteses Valvulares Cardíacas/microbiologia , Infecções por Bactérias Gram-Positivas/microbiologia , Infecções por Bactérias Gram-Positivas/diagnóstico , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Firmicutes/isolamento & purificação , Firmicutes/genética , Masculino , Antibacterianos/uso terapêutico , Sequenciamento de Nucleotídeos em Larga Escala , Pessoa de Meia-Idade
18.
J Investig Med High Impact Case Rep ; 12: 23247096241262718, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39044602

RESUMO

Bartonella species are gram-negative coccobacilli that are globally recognized as significant pathogens causing zoonotic infections. Among Bartonella species, B. henselae, B. quintana, and B. bacilliformis are prominent pathogens causing infections in humans, often manifesting as infective endocarditis. Bartonella endocarditis can pose diagnostic challenges due to its indolent presentation and limitations of standard microbiological culture techniques to identify the organism. We report a case of a 23-year-old male, who initially presented with the manifestations of hepatosplenic T-cell lymphoma, later diagnosed with blood culture-negative endocarditis caused by B. henselae. The patient had a complicated clinical course including pancytopenia, hepatosplenomegaly, and severe aortic valve regurgitation. Despite negative blood cultures, diagnostic clues included persistent fevers and bicuspid aortic valve with abscess. High Bartonella IgG titers (>1:800) supported the diagnosis. This case underscores the importance of considering Bartonella species in patients with suspected endocarditis, particularly in those with predisposing factors and negative blood cultures. Diagnosis relies heavily on serologic assays due to low sensitivity of conventional culture methods. Treatment involves a multidisciplinary approach with antibiotics and surgical intervention for optimal outcomes. Timely recognition and management are crucial to mitigate the high mortality associated with Bartonella endocarditis, and we hope this article offers insight for clinicians.


Assuntos
Bartonella henselae , Endocardite Bacteriana , Linfoma de Células T , Humanos , Masculino , Bartonella henselae/isolamento & purificação , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/diagnóstico , Endocardite Bacteriana/tratamento farmacológico , Linfoma de Células T/complicações , Linfoma de Células T/diagnóstico , Adulto Jovem , Neoplasias Esplênicas/complicações , Doença da Arranhadura de Gato/diagnóstico , Doença da Arranhadura de Gato/complicações , Doença da Arranhadura de Gato/tratamento farmacológico , Neoplasias Hepáticas
20.
J Antimicrob Chemother ; 79(8): 2017-2021, 2024 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-38958234

RESUMO

OBJECTIVES: To investigate clinical outcomes of patients with Pseudomonas endocarditis and identify factors associated with treatment failure. METHODS: Adult patients meeting definitive Duke's criteria for Pseudomonas endocarditis at 11 hospitals were identified between May 2000 and February 2024. Failure was defined as death or microbiological failure by day 42. First-line therapy consisted of cefepime, piperacillin/tazobactam, ceftazidime or ceftolozane/tazobactam alone or in combination. RESULTS: Forty-eight patients met inclusion criteria; 29% were persons who inject drugs and 13% were organ transplant recipients. Pseudomonas aeruginosa was the causative species in 98% of cases. Patients who experienced 42 day cure were more likely to be initially managed with first-line ß-lactam agents compared with those who experienced clinical failure (97% versus 62%, P = 0.004). Treatment with first-line ß-lactams was associated with shorter time to treatment initiation and a lower likelihood of infection due to MDR Pseudomonas spp. In the univariate model, patients who experienced 90 day mortality were more likely to have prosthetic valve endocarditis (57% versus 24%, P = 0.02), an intracardiac complication (36% versus 9%, P = 0.04) and a higher median (IQR) Pitt bacteraemia score [2.5 (2-3.8) versus 1 (0-2), P = 0.048]. Combination therapy did not improve clinical outcomes but did increase the rate of adverse effects resulting in drug discontinuation compared with monotherapy, (21% versus 0%, P = 0.08). CONCLUSIONS: This is the largest study of Pseudomonas endocarditis to date. We identified improved clinical outcomes when cefepime, piperacillin/tazobactam, ceftazidime or ceftolozane/tazobactam were used for initial treatment. We did not identify a clinical benefit for combination treatment.


Assuntos
Antibacterianos , Endocardite Bacteriana , Infecções por Pseudomonas , Pseudomonas aeruginosa , Humanos , Infecções por Pseudomonas/tratamento farmacológico , Infecções por Pseudomonas/microbiologia , Infecções por Pseudomonas/mortalidade , Masculino , Feminino , Pessoa de Meia-Idade , Antibacterianos/uso terapêutico , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/microbiologia , Endocardite Bacteriana/mortalidade , Adulto , Idoso , Pseudomonas aeruginosa/efeitos dos fármacos , Resultado do Tratamento , Tazobactam/uso terapêutico , Estudos Retrospectivos , Falha de Tratamento , Combinação Piperacilina e Tazobactam/uso terapêutico , Cefalosporinas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...